cystamine and trinitrobenzenesulfonic acid

cystamine has been researched along with trinitrobenzenesulfonic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagnis, C; Berruyer, C; Canonici, A; Galland, F; Garcia, S; LeGoffic, A; Martin, FM; Millet, V; Naquet, P; Pouyet, L	1
Bardella, MT; Bonura, A; Braidotti, P; Busca, G; Ciulla, MM; Elli, L; Ferrero, S; Maioli, C; Paliotti, R; Roncoroni, L; Terrani, C	1

Other Studies

2 other study(ies) available for cystamine and trinitrobenzenesulfonic acid

Article	Year
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. The Journal of experimental medicine, 2006, Dec-25, Volume: 203, Issue:13 Topics: Active Transport, Cell Nucleus; Amidohydrolases; Animals; Benzhydryl Compounds; Body Weight; Cell Adhesion Molecules; Cell Line; Cell Nucleus; Chemokine CCL2; Chemokine CXCL2; Chemokines; Colitis; Colon; Cyclooxygenase 2; Cystamine; Cytokines; Epithelial Cells; Epoxy Compounds; Gene Expression Regulation; GPI-Linked Proteins; Interleukin-1beta; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, SCID; PPAR gamma; Prostaglandin D2; Survival Analysis; Trinitrobenzenesulfonic Acid	2006
Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:3 Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Cystamine; Enzyme Inhibitors; Female; GTP-Binding Proteins; Humans; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Male; Middle Aged; Protein Glutamine gamma Glutamyltransferase 2; Random Allocation; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Transglutaminases; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011

Article

Year

Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.

The Journal of experimental medicine, 2006, Dec-25, Volume: 203, Issue:13

Topics: Active Transport, Cell Nucleus; Amidohydrolases; Animals; Benzhydryl Compounds; Body Weight; Cell Adhesion Molecules; Cell Line; Cell Nucleus; Chemokine CCL2; Chemokine CXCL2; Chemokines; Colitis; Colon; Cyclooxygenase 2; Cystamine; Cytokines; Epithelial Cells; Epoxy Compounds; Gene Expression Regulation; GPI-Linked Proteins; Interleukin-1beta; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, SCID; PPAR gamma; Prostaglandin D2; Survival Analysis; Trinitrobenzenesulfonic Acid

2006

Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.

Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:3

Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Cystamine; Enzyme Inhibitors; Female; GTP-Binding Proteins; Humans; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Male; Middle Aged; Protein Glutamine gamma Glutamyltransferase 2; Random Allocation; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Transglutaminases; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2011